Book a free demo with us
Book Now
Beyond Air
Formerly AIT Therapeutics
Beyond Air, Inc. operates as a medical device and biopharmaceutical company. We are led by a team committed to revolutionizing nitric oxide therapy with the LungFit product family.
Total Fundraised$5B
PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
2011
Garden City, New York, United States
ISR
USA
Biotechnology
Medical
Medical Device
Healthcare
11 - 50
Post-IPO Equity
https://www.beyondair.net/Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
Beyond Air's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Beyond Air's
Key Team Members
Social Media
© 2025 Lucidity Insights.
